Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Huntington Ingalls Buys S.M. Stoller

RELATED NEWS
Trade HII now with 

Huntington Ingalls Industries, Inc. (HII: Quote) said Thursday that it has bought The S.M. Stoller Corp., a provider of environmental, nuclear, and technical consulting and engineering services to the Department of Energy, Department of Defense and the private sector.

Stoller is a privately held company and performs work in 29 states from 18 offices across the U.S.

The value of the deal was not disclosed.

Stoller will be a wholly owned subsidiary of Huntington Ingalls Industries and will operate under its NNS division. NNS is the nation's sole designer, builder and refueler of nuclear-powered aircraft carriers and one of only two shipyards capable of designing and building nuclear-powered submarines.

Click here to receive FREE breaking news email alerts for Huntington Ingalls Industries and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks saw some volatility following the release of the Federal Reserve's monetary policy announcement on Wednesday but managed to end the day modestly higher. With the upward move, the Dow reached a new record closing high. President Barack Obama sought to emphasize in remarks on Wednesday that the American forces being deployed as part of the fight against the terrorist group ISIS will not have a combat mission. Republican Joni Ernst has moved into the lead in the potentially crucial Iowa Senate race, according to the results of a Quinnipiac University poll released on Wednesday. The poll found that 50 percent of likely Iowa voters would support Ernst if the election were held today, while 44 percent would vote for Democratic Rep. Bruce Braley.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.